Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “GLUTAMIC ACID”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 991 records · Page 55Linked to original sources

Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator.

Within chromatin, reversible acetylation of core histones is critical for transcriptional activation of eukaryotic target genes. The recent identification of intrinsic histone acetyltransferase (HAT) catalytic activity from a number of transcriptional co-activators (including yeast GCN5, p300/CBP, P/CAF, and TAFII250), has underscored the importance of protein acetylation in transcriptional control. The GCN5 family is the prototype for a diverse group of at least four distinct human HATs families. Although there is now a clear link between in vivo HAT catalytic activity and gene activation, little is known about the molecular mechanisms of histone acetylation. Herein, we report the first detailed biochemical study that probes the catalytic mechanism and the function of invariant glutamic acid 173 within the GCN5 family of HATs. Our results suggest that the HAT reaction involves the formation of a ternary complex (histones, acetyl-CoA, and enzyme) where the epsilon-amino group of histone lysine residues directly attacks the bound acetyl-CoA. The acetylation reaction requires deprotonation of the epsilon-amino group prior to nucleophilic attack. Employing site-directed mutagenesis, chemical modification, steady-state, and pH-dependent rate analysis, it is demonstrated that glutamic acid 173 is an essential catalytic residue, acting as a general base catalyst by deprotonating the histone substrate.

Acetyl Coenzyme A↗

A glutamic acid producing Streptomyces sp.

Following the bioautographic technique, a strain of Streptomyces sp. has been isolated producing L-glutamic acid. The strain in able to grow and produce glutamate in mineral salt medium, but supplementation with yeast extract improved the yield.

Culture Media↗

Agonistic behavior and its cardiovascular components elicited by microinjection of L-glutamic acid into the basal midbrain of the toad Bufo paracnemis.

Microinjection of L-glutamic acid into the basal midbrain of the toad Bufo paracnemis induced a series of responses linked to antipredator behavior such as flight, backward locomotion and defensive postures. Furthermore, alerting/orientation occurred in 20% of the animals, a behavior which is probably important for the animal to achieve the above responses. Locomotion occurred in 18% of the toads. The existence of a mesencephalic premotor control for locomotion in these animals is discussed comparatively. All responses were accompanied by changes in arterial pressure, heart rate and intrabuccal pressure. In some animals which exhibited backward locomotion responses, defensive postures and alerting/orientation, bradycardia or cardiac arrest occurred, with no appreciable changes in arterial pressure. This fact is discussed on the basis of studies which have shown the occurrence of similar alterations in situations of fear in other vertebrates. Autonomic changes without other responses occurred in 16% of the animals. Flight behavior was usually observed as a consequence of stimulation of sites located in the anterodorsal tegmental nucleus and lateral portions of the midbrain tegmentum. In contrast, locomotion was obtained by stimulating basal sites of the tegmentum located in the anteroventral nucleus and in the reticular formation lateral to it. Sites related to the remaining behaviors were located more diffusely in the basal midbrain.

Agonistic Behavior↗

Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.

This study addresses genetic factors associated with normal variation of the CAG repeat in the Huntington disease (HD) gene. To achieve this, we have studied patterns of variation of three trinucleotide repeats in the HD gene including the CAG and adjacent CCG repeats as well as a GAG polymorphism at residue 2642 (delta 2642). We have previously demonstrated that variation in the CCG repeat is associated with variation of the CAG repeat length on normal chromosomes. Here we show that differences in the GAG trinucleotide polymorphism at residue 2642 is also significantly correlated with CAG size on normal chromosomes. The B allele which is associated with higher CAG repeat lengths on normal chromosomes is markedly enriched on affected chromosomes. Furthermore, this glutamic acid polymorphism shows significant variation in different ancestries and is absent in chromosomes of Japanese, Black and Chinese descent. Haplotype analysis of both the CCG and delta 2642 polymorphisms have indicated that both are independently associated with differences in CAG length on normal chromosomes. These findings lead to a model for the genetic evolution of new mutations for HD preferentially occurring on normal chromosomes with higher CAG repeat lengths and a CCG repeat length of seven and/or a deletion of the glutamic acid residue at delta 2642. This study also provides additional evidence for genetic contributions to demographic differences in prevalence rates for HD.

Alleles↗

Aliphatic hydrocarbons of Cladosporium resinae cultured on glucose, glutamic acid, and hydrocarbons.

The carbon source markedly influenced the qualitative and quantitative composition of cellular hydrocarbons in Cladosporium resinae. Total lipid and hydrocarbon content was greater in cells grown on n-alkanes than in cells grown on glucose or glutamic acid. Glucose-grown cells contained a spectrum of aliphatic hydrocarbons from C(7) to C(36); pristane and n-hexadecane comprised 98% of the total. Cells grown on glutamic acid contained C(7) to C(23) hydrocarbons; n-tridecane, n-tetradecane, n-hexadecane, and pristane made up 74% of the total. n-Decane-grown cells yielded C(8) to C(32) compounds, and n-hexadecane (96%) was the major hydrocarbon. Cells grown on individual n-alkanes from C(11) to C(15) all contained C(11) to C(28) hydrocarbons, and cells grown on n-hexadecane contained C(11) to C(32) hydrocarbons. In n-undecane-grown cells, n-hexadecane and pristane made up 92% of the total, but in cells grown on C(12) to C(16)n-alkanes the major cellular hydrocarbon was the one on which the cells were grown. This suggests that cells cultured on n-alkanes of C(12) or longer accumulate n-alkanes prior to oxidizing them.

Alkanes↗

Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: comparison with glutamic acid decarboxylase67 (GAD67) mRNA localization.

The mRNA expression of GABA transporter 1 (GAT1) was investigated in the rat brain by in situ hybridization histochemistry using an oligonucleotide probe specific to the mRNA. The pattern of GABA transporter 1 mRNA expression was well coincident with that of GABAergic terminals detected by using glutamic acid decarboxylase (GAD) as a marker. In addition, we compared the GAT1 mRNA expression with that of glutamic acid decarboxylase67 (GAD67) mRNA positive neurons. Although the expression patterns of both mRNAs were similar in most nuclei, the number of GABA transporter 1 mRNA positive cells were higher than that of GAD67 mRNA positive cells in some nuclei, such as the inferior colliculus, cerebellar nuclei and cerebral cortex. Furthermore the subthalamic nucleus and inferior olive nucleus, which lacked GAD67 mRNA expression, showed intense GABA transporter 1 mRNA expression. These data suggest that GABA transporter 1 mRNA is expressed not only in GABAergic neurons but also in non-GABAergic neurons and/or glial cells which are involved in GABAergic neurotransmission.

Animals↗

A substructure approach toward polymeric receptors targeting dihydrofolate reductase inhibitors. 2. Molecularly imprinted polymers against Z-l-glutamic acid showing affinity for larger molecules.

The preparation of a molecularly imprinted polymer against N-Z-L-glutamic acid using a novel bis-urea functional monomer is described. The polymer exhibits affinity for the template over N-Z-protected aspartic acid and glycine and, further, is capable of binding larger molecules, e.g., the anti-cancer drug methotrexate, containing the glutamate substructure.

Enzyme Inhibitors↗

LGN-projecting neurons of the cat's pretectum express glutamic acid decarboxylase mRNA.

There have been conflicting reports on the chemical nature of the projection of the pretectal nuclei [nucleus of the optic tract and dorsal terminal nucleus of the accessory optic tract (NOT-DTN complex) and posterior pretectal nucleus] to the lateral geniculate nucleus and inferior olive. There is evidence that the pretecto-geniculate pathway is inhibitory. However, most attempts to verify the GABAergic nature of the projection neurons have failed. In order to answer this question, we employed a combination of retrograde transport and in situ hybridization. Rhodamine-labelled latex microspheres were injected into the electrophysiologically identified lateral geniculate nucleus. In addition, fluorescein-labelled latex microspheres were injected into the inferior olive. Retrograde axonal transport labelled large pretectal neurons. We then applied riboprobes specific for glutamic acid decarboxylase mRNA. We were able to demonstrate glutamic acid decarboxylase mRNA expression in up to 70% of lateral geniculate nucleus-projecting NOT-DTN and posterior pretectal nucleus neurons but in none of the pretecto-olivary projection neurons. The results suggest that the pretecto-geniculate projection is GABAergic in nature, which would confirm previous electrophysiological and morphological observations. The pretecto-olivary projection is not GABAergic.

Animals↗

[Effect of pyridoxine, riboflavin and glutamic acid on lysosomal hydrolase activity in the liver and serum of rats during traumatic stress].

The content of 5 lysosomal hydrolases was examined in the rat liver and blood serum after compression of hind limb soft tissues in the presence of a long-term intake of excess doses of pyridoxine, riboflavin and glutamic acid. It was shown that the 14-day application of the drug complexes dramatically increased the overall content of cathepsin C, arylsulfatases A and B, beta-glucuronidase and p-acetyl-beta-D-galactosaminidase and reduced the overall content of cathepsin D in the rat liver. The non-sedimented content of the enzymes did not practically differ from the control magnitudes. In the blood serum, the content of cathepsin C and B1 approximated that seen in the control, while that of arylsulfatases A and B and p-acetyl-beta-D-galactosaminidase decreased, whereas the beta-glucuronidase content was 75% higher as compared to the basic characteristics. In the presence of administering the drug complexes, severe mechanical injury entailed the lowering of the content of the majority of rat liver lysosomal hydrolases. Besides, one could observe an essential fall of the non-sedimented content of cathepsin C and arylsulfatases A and B. The blood serum demonstrated an appreciable decrease in the content of cathepsins C and B1, p-acetyl-beta-D-galactosaminidase and arylsulfatases A and B. Thus, the fall of the non-sedimented content and diminished release of lysosomal hydrolases into the systemic circulation attest to the preservation of the structural and functional integrity of the liver cell lysosomal system during severe mechanical injury in the presence of combined excess intake of pyridoxine, riboflavin and glutamic acid.

Animals↗

[The kinetics of the postmortal bacterial metabolism of the glutamic acid in brain (author's transl)].

This paper gives a brief report on investigations on bacterial enzyme activities in putrefied brain tissue. The effects of temperature changes (5--30 degrees C) and pH-changes (3--8) on the rate of the glutamic acid reactions, especially proteolysis and alpha- resp. gamma-decarboxylation, were examined to reveal to which extent a temperature and pH-independence is valid for the previously developed time of death formula: (formula: see text). The present investigation demonstrates the independence of the mentioned formula for the important pH-range of 6--7.2 and for a temperature range of 17.5--25 degrees C (room temperature). A second important result is that in these ranges a high proteolytic activity is observed so that the continuation of the reaction sequences will be maintained. These results reveal that the postmortal metabolism of the glutamic acid may be suitable to determine the time of death.

Aminobutyrates↗

Poly(L-glutamic acid)--anticancer drug conjugates.

Chemotherapy has had limited success in the treatment of cancer over the years, due, in part, to the untoward toxicity of the therapeutic agent to normal cells. The design of tailor-made polymer conjugates provides a synthetic approach that can overcome some of the problems. Several synthetic polymer-based anticancer drug conjugates have entered clinical studies. This report reviews the chemistry, physicochemical properties, and therapeutic applications in cancer therapy of polymeric chemotherapeutic agents based on poly(L-glutamic acid). Targeted delivery of anticancer agents using poly(L-glutamic acid) as the drug carrier is also discussed with emphasis on the design of innovative polymeric constructs.

Anthracyclines↗